When should we delay highly active antiretroviral therapy?
- 1 July 1999
- journal article
- editorial
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 14 (7), 446-448
- https://doi.org/10.1046/j.1525-1497.1999.05109.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of PrisonersEuropean Respiratory Journal, 1998
- Depression, Adherence Behavior, and Coronary Disease OutcomesArchives of Internal Medicine, 1998
- Adherence to a Prophylactic Medication Regimen in Patients With Symptomatic Versus Asymptomatic Ischemic Heart DiseaseBehavioral Medicine, 1998
- Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: Main and matching effects.Journal of Consulting and Clinical Psychology, 1998
- Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance.Thorax, 1996
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996
- Pain Assessment and EthnicityAnnals of Emergency Medicine, 1996
- Compliance and Outcomes in Patients with AsthmaDrugs, 1996
- The Relation of Stress and Depression to Interdialytic Weight Gain in Hemodialysis PatientsBehavioral Medicine, 1995
- Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban CommunityNew England Journal of Medicine, 1994